Cutivate Related Published Studies
Well-designed clinical trials related to Cutivate (Fluticasone Topical)
Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial. [2008.10]
Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children. [2008.09]
Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. [2008.08]
Comparison of a Combination of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Moderate COPD. [2008.08]
Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial. [2008.07.02]
Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD. [2008.07]
Respirable dose delivery of fluticasone propionate from a small valved holding chamber, a compact breath actuated integrated vortex device and a metered dose inhaler. [2008.07]
Fluticasone and ibuprofen do not add to the effect of salmeterol on organic dust-induced airway inflammation and bronchial hyper-responsiveness. [2008.07]
The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. [2008.06.01]
Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. [2008.06]
Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma. [2008.06]
Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber. [2008.06]
Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone. [2008.06]
Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD. [2008.06]
Breath-synchronized plume-control inhaler for pulmonary delivery of fluticasone propionate. [2008.05.22]
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]
Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis. [2008.05]
Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray. [2008.05]
Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial. [2008.04]
Efficacy and safety of fluticasone propionate/salmeterol 250/50mcg Diskus administered once daily. [2008.04]
CT detected indeterminate pulmonary nodules in a chemoprevention trial of fluticasone. [2008.04]
Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. [2008.02]
Efficacy of fluticasone metered-dose inhaler and dry powder inhaler for pediatric asthma. [2008.02]
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. [2008.01.01]
Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. [2008.01]
Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis. [2008.01]
Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma. [2008.01]
Endocrine and immunologic effects of inhaled fluticasone propionate in healthy dogs. [2008.01]
Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison. [2008]
Salmeterol/Fluticasone Propionate via Diskustrade mark Once Daily versus Fluticasone Propionate Twice Daily in Patients with Mild Asthma not Previously Receiving Maintenance Corticosteroids. [2008]
The Efficacy and Safety of Combination Salmeterol (50 {micro}g)/Fluticasone Propionate (500 {micro}g) Inhalation Twice Daily Via Accuhaler in Chinese Patients With COPD. [2007.12]
Comparison of the efficacy of salmeterol/fluticasone propionate combination in Japanese and Caucasian asthmatics. [2007.12]
Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations. [2007.12]
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. [2007.12]
Comparison of add-on therapy to inhaled fluticasone propionate in children with asthma: residual volume and exhaled nitric oxide as outcome measures. [2007.11]
Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study. [2007.11]
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. [2007.11]
Initiation of maintenance treatment with salmeterol/fluticasone propionate 50/100 microg bd versus fluticasone propionate 100 microg bd alone in patients with persistent asthma: integrated analysis of four randomised trials. [2007.11]
Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. [2007.10]
Comparison of a step-down dose of once-daily ciclesonide with a continued dose of twice-daily fluticasone propionate in maintaining control of asthma. [2007.10]
Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction. [2007.10]
Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma. [2007.09.27]
Similar efficacy of ciclesonide once daily versus fluticasone propionate twice daily in patients with persistent asthma. [2007.09]
Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. [2007.09]
Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis. [2007.09]
Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients. [2007.09]
Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. [2007.09]
Anti-inflammatory effects of high-dose inhaled fluticasone versush oral prednisone in moderate asthma exacerbations. A randomized clinical trial. [2007.08.09]
A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma. [2007.08]
A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis. [2007.08]
Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma. [2007.07.14]
Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life. [2007.07.04]
Absolute bioavailability of intranasal fluticasone furoate in healthy subjects. [2007.07]
Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate. [2007.07]
Beclometasone dipropionate extrafine aerosol versus fluticasone propionate in children with asthma. [2007.07]
Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. [2007.07]
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD:a randomized controlled trial. [2007.06.08]
Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. [2007.06]
[A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between hfa-bdp and fluticasone propionate] [2007.06]
Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate alone. [2007.06]
A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. [2007.06]
The influence of fluticasone inhalation on markers of carcinogenesis in bronchial epithelium. [2007.05.15]
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. [2007.04.17]
Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD. [2007.04]
Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD. [2007.04]
Potency ratio fluticasone propionate (Flixotide Diskus)/budesonide (Pulmicort Turbuhaler). [2007.03]
Daytime sleepiness and cognitive performance improve in seasonal allergic rhinitis treated with intranasal fluticasone propionate. [2007.03]
Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents. [2007.03]
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. [2007.02.22]
Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD. [2007.01.23]
Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. [2007.01]
Combination therapy with the single inhaler salmeterol/fluticasone propionate versus increased doses of inhaled corticosteroids in patients with asthma. [2007]
Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma. [2007]
A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. [2006.11]
Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: a randomized, double-blind, placebo-controlled study. [2006.11]
Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized study. [2006.11]
A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma. [2006.10]
Combination Therapy with the Single Inhaler Salmeterol/Fluticasone Propionate versus Increased Doses of Inhaled Corticosteroids in Patients with Asthma. [2006.09.27]
Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone. [2006.09]
Duration of action of the salmeterol/fluticasone combination inhaler administered in the evening: a randomized controlled trial in childhood asthma. [2006.09]
Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study. [2006.08.26]
High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma. [2006.08]
Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease in the presence of missing data. [2006.07]
Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate. [2006.07]
Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol. [2006.07]
Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. [2006.06]
Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study. [2006.06]
Comparison of three valved holding chambers for the delivery of fluticasone propionate-HFA to an infant face model. [2006.06]
Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses. [2006.06]
Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis. [2006.05]
Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. [2006.04.01]
Two randomized, double-blind, placebo-controlled studies of fluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from 3 months of age. [2006.04]
Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma. [2006.04]
Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978]. [2006.02.06]
Non-viral wheezing in preschool children: the effect of inhaled fluticasone on symptoms and lung function. [2006.02]
Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. [2006.01]
Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids. [2006.01]
Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. [2006.01]
Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. [2006.01]
Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization. [2006]
Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination. [2006]
|
